Last Updated: July 26, 2026

List of Excipients in API tofacitinib citrate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing tofacitinib citrate

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Padagis US LLC	tofacitinib citrate	0574-1811	AMMONIA
Padagis US LLC	tofacitinib citrate	0574-1811	CELLULOSE ACETATE
Padagis US LLC	tofacitinib citrate	0574-1811	COPOVIDONE K25-31
Padagis US LLC	tofacitinib citrate	0574-1811	FERRIC OXIDE RED
Padagis US LLC	tofacitinib citrate	0574-1811	FERRIC OXIDE YELLOW
Padagis US LLC	tofacitinib citrate	0574-1811	FERROSOFERRIC OXIDE
Padagis US LLC	tofacitinib citrate	0574-1811	HYDROXYETHYL CELLULOSE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for tofacitinib citrate

Excipient focus: AMMONIA

tofacitinib citrate drug variants containing AMMONIA

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing AMMONIA

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE ACETATE

tofacitinib citrate drug variants containing CELLULOSE ACETATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing CELLULOSE ACETATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

tofacitinib citrate drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

Excipient focus: COPOVIDONE K25-31

tofacitinib citrate drug variants containing COPOVIDONE K25-31

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing COPOVIDONE K25-31

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

tofacitinib citrate drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

tofacitinib citrate drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

tofacitinib citrate drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

tofacitinib citrate drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYETHYL CELLULOSE

tofacitinib citrate drug variants containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

tofacitinib citrate drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

tofacitinib citrate drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2910

tofacitinib citrate drug variants containing HYPROMELLOSE 2910

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing HYPROMELLOSE 2910

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

tofacitinib citrate drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

tofacitinib citrate drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL

tofacitinib citrate drug variants containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

tofacitinib citrate drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: SHELLAC

tofacitinib citrate drug variants containing SHELLAC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing SHELLAC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

tofacitinib citrate drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: SORBITOL

tofacitinib citrate drug variants containing SORBITOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing SORBITOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: TALC

tofacitinib citrate drug variants containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

tofacitinib citrate drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Padagis US LLC	tofacitinib citrate	0574-1811
Breckenridge Pharmaceutical Inc	tofacitinib citrate	51991-329
>Company	>Ingredient	>NDC

tofacitinib citrate drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.